Skip to main content
. 2018 Dec 26;16(1):93–103. doi: 10.1080/15476286.2018.1559689

Table 1.

The top 10 significant differentially expressed miRNAs/miRNA candidates in patients with disease (all diseases combined, n = 116) compared with controls (all controls combined, n = 71).

miRNA miRCarta ID Median control Median disease Fold change (median control/median disease) Wilcoxon rank sum test p-value (two-tailed, FDR adjusted)
TJU_CMC_MD2-miR-ID02529-5p m-4408 29.44 64.94 0.45 3.33E-10
hsa-miR-4516 m-482 671.33 987.57 0.68 2.59E-09
hsa-miR-93-3p m-250 13.78 8.44 1.63 8.73E-09
hsa-miR-92b-3p m-115 7.04 6.31 1.12 8.73E-09
TJU_CMC_MD2-miR-ID00168-3p m-4357 37.55 20.49 1.83 1.16E-08
TJU_CMC_MD2-miR-ID02570-3p m-4481 25.37 14.03 1.81 1.8E-08
hsa-miR-631 m-1536 4.87 5.15 0.94 1.86E-08
novel-miR-1180-3p m-5609 13.14 8.36 1.57 3.7E-08
hsa-miR-331-3p m-192 630.59 375.18 1.68 3.9E-08
hsa-miR-339-5p m-163 101.08 48.26 2.09 5.01E-08